TRAP1-IN-2
TRAP1-IN-2 is a TRAP1-selective inhibitor, with a Kd value of 0.04 μM against human TRAP1. TRAP1-IN-2 exhibits more than 250-fold selectivity for Grp94 and shows no detectable affinity for cytosolic Hsp90α/β. TRAP1-IN-2 selectively induces the degradation of TRAP1 client proteins by inhibiting its ATPase activity, without triggering the heat shock response or affecting cytosolic Hsp90 client proteins. TRAP1-IN-2 suppresses oxidative phosphorylation, shifts cellular metabolism toward glycolysis, disrupts the stability of the TRAP1 tetramer and the mitochondrial membrane potential. TRAP1-IN-2 can be used in studies related to prostate cancer, cervical cancer, and ovarian cancer.
For research use only. We do not sell to patients.
- CAS No.: 3031102-92-5
- Formula: C46H42F6N2O5P2
- Molecular Weight:878.77
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
TRAP1 0.04 μM (Kd) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 22Rv1 | IC50 |
10.1 μM
|
Antiproliferative activity against human 22Rv1 cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTS/PMS assay.
Antiproliferative activity against human 22Rv1 cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTS/PMS assay.
|
37307624 |
| HeLa | IC50 |
16.4 μM
|
Antiproliferative activity against human HeLa cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTS/PMS assay.
Antiproliferative activity against human HeLa cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTS/PMS assay.
|
37307624 |
| PC-3 | IC50 |
23.9 μM
|
Antiproliferative activity against human PC3 cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTS/PMS assay.
Antiproliferative activity against human PC3 cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTS/PMS assay.
|
37307624 |
In Vitro
TRAP1-IN-2 (compound 36) (72 h) inhibits the proliferation of 22Rv1, HeLa and PC3 human cancer cells, with IC50 values of 10.1 μM, 16.4 μM and 23.9 μM, respectively[1].
TRAP1-IN-2 (24 h) binds to purified human TRAP1 with a Kd value of 0.04 μM, exhibiting over 250-fold selectivity over Grp94[1].
TRAP1-IN-2 (1-50 μM; 6 h) selectively induces the degradation of the TRAP1 client proteins NDUFS1, glutaminase-1, and Sirt3 in a dose-dependent manner in HeLa and 22Rv1 cells, without altering the levels of cytosolic Hsp90 client proteins or inducing Hsp70 expression[1].
TRAP1-IN-2 (5-50 μM; 6 h) significantly inhibits oxidative phosphorylation (OXPHOS) in HeLa and 22Rv1 cells in a dose-dependent manner, including basal respiration, proton leak, maximal respiration, non-mitochondrial O2 consumption, and spare respiratory capacity[1].
TRAP1-IN-2 (5-50 μM; 6 h) disrupts the mitochondrial membrane potential in HeLa cells, as evidenced by a dose-dependent reduction in TMRM fluorescence[1].
TRAP1-IN-2 (5-50 μM; 6 h) alters the cellular metabolism of HeLa cells by reducing mitochondrial ATP production and increasing glycolytic ATP production in a dose-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HeLa and 22Rv1 human cancer cell lines
-
Concentration:1, 5, 10, 25, 50 μM
-
Incubation Time:6 h
-
Result:Induced dose-dependent degradation of TRAP1 client proteins NDUFS1, Glutaminase-1, and Sirt3 in HeLa cells.
Induced dose-dependent degradation of TRAP1 client proteins NDUFS1, Glutaminase-1, and Sirt3 in 22Rv1 cells.
Did not induce degradation of cytosolic Hsp90 clients Akt and CDK4.
Did not increase Hsp70 expression.
Chemical Information
-
CAS No. 3031102-92-5
-
Molecular Weight 878.77
-
Formula C46H42F6N2O5P2
-
SMILES
O=C(C1=C(O)C=CC(C(N2CC(C(OC)=CC=C3)=C3C2)=O)=C1)N(C4)CC5=C4C=CC(OCCC[P+](C6=CC=CC=C6)(C7=CC=CC=C7)C8=CC=CC=C8)=C5.F[P-](F)(F)(F)(F)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)